Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 19 - Hybrid peptides
Patents for C07K 19 - Hybrid peptides (29,428)
11/2003
11/06/2003WO2003091414A2 Adipocyte complement related protein zacrp8
11/06/2003WO2003091413A2 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003WO2003091266A2 Protein stabilisation using chaperone proteins
11/06/2003WO2003090514A2 Adipocyte complement related protein zacrp14
11/06/2003WO2003026700A3 Compositions for transporting antibodies through the blood brain barrier and their use for diagnosing or treating central nervous system diseases
11/06/2003WO2003012069A3 Compositions and methods for generating chimeric heteromultimers
11/06/2003WO2003011878A3 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
11/06/2003WO2003002604A3 G protein coupled receptors and dna sequences thereof
11/06/2003WO2002094313A3 Vaccine composition
11/06/2003WO2002072600A3 Monoclonal antibodies to the clfa protein and method of use in treating or preventing infections
11/06/2003WO2002066649A8 ANTI-INTERFERON-α ANTIBODIES
11/06/2003WO2002061105A3 Chimeric molecules containing a module able to target specific cells and a module regulating the apoptogenic function of the permeability transition pore complex (ptpc)
11/06/2003WO2002057792A3 Affinity selection-based screening of hydrophobic proteins
11/06/2003WO2002053742A3 Proteins and nucleic acids encoding same
11/06/2003WO2002044210A3 Novel human nucleic acid molecules and polypeptides encoding a novel human ion channel expressed in spinal cord and brain
11/06/2003WO2002024891A9 B7-like molecules and uses thereof
11/06/2003WO2001078503A3 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
11/06/2003US20030208783 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins
11/06/2003US20030208046 Pseudo native chemical ligation
11/06/2003US20030207403 For diagnosis or treatment of diseases with beta 10 polypeptides and alpha 2/ beta 10 heterodimers or their respective binding agents, such as thyroid gland disorders
11/06/2003US20030207293 Cryptic-like secreted protein
11/06/2003US20030206900 Vectors derived from antibodies for transferring substances into cells
11/06/2003CA2483337A1 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
11/06/2003CA2480845A1 Adipocyte complement related protein zacrp8
11/06/2003CA2480291A1 Adipocyte complement related protein zacrp14
11/05/2003EP1359222A2 Hybrid human/porcine factor VIII
11/05/2003EP1358485A2 Methods for identifying compounds for regulating muscle mass or function using vasoactive intestinal peptide receptors
11/05/2003EP1358336A2 Human serine-threonine kinase
11/05/2003EP1358329A2 Lipid-associated molecules
11/05/2003EP1358328A2 Regulation of human serotonin-like g protein-coupled recepter
11/05/2003EP1357940A2 Hepatitis b virus treatment
11/05/2003CN1454216A Antibodies to CCR5
11/05/2003CN1454215A Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
11/05/2003CN1454097A Polymer-modified synthetic proteins
11/05/2003CN1453294A Fusion and solubility expression of cobratoxin and acidolysis release and purification of recombinant toxin
11/04/2003US6642359 Peptide or protein for use in the diagnosis, treatment or prophylaxis of viral disease
11/04/2003US6641812 Heat shock protein-based vaccines and immunotherapies
10/2003
10/30/2003WO2003089620A2 Phospholipases, nucleic acids encoding them and methods for making and using them
10/30/2003WO2003089584A2 Use of parapox b2l protein to modify immune responses to administered antigens
10/30/2003WO2003089475A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
10/30/2003WO2003089450A2 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003WO2003088995A2 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003WO2003039491A8 Novel isoforms of vascular endothelial cell growth inhibitor
10/30/2003WO2003000877A3 A soluble complex comprising a retroviral surface glycoprotein
10/30/2003WO2002097030A3 Peptides derived from neural thread proteins and their medical use
10/30/2003US20030204864 Stable plastid transformation and expression vector for transferring target nucleotide sequences into plants for mass production of affordable vaccines and pharmaceutical agents
10/30/2003US20030204863 Nav2 channel gene-deficient non-human animals
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003CA2483476A1 Fusion polypeptides and methods for inhibiting microbial adhesion
10/30/2003CA2483473A1 Mucin fusion polypeptide vaccines, compositions and methods of use thereof
10/30/2003CA2482607A1 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi
10/30/2003CA2481411A1 Phospholipases, nucleic acids encoding them and methods for making and using them
10/29/2003EP1356285A2 Differentially expressed epitopes and uses thereof
10/29/2003EP1356075A2 Protein scaffolds for antibody mimics and other binding proteins
10/29/2003EP1356066A2 Control of gene expression in plants
10/29/2003EP1356028A2 Protein modification and maintenance molecules
10/29/2003EP1355942A2 Glp-1 fusion proteins
10/29/2003EP1355936A2 Polymer conjugates of neublastin and methods of using same
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355919A2 Molecules with extended half-lives, compositions and uses thereof
10/29/2003EP1355918A2 Recombinant protective protein from $i(streptococcus pneumoniae)
10/29/2003EP0946736B1 Method for expression of heterologous proteins in yeast
10/29/2003EP0682710B1 Isolation process using immobilized proteins with specific binding capacities
10/29/2003EP0627000B1 Mammalian expression systems for hcv proteins
10/29/2003CN1452636A Human monoclonal antibodies to dendritis cells
10/29/2003CN1452635A Recombinant fusion protein for diagnosis of tsutsugamushi disease
10/29/2003CN1451666A Recombinant fusion resisting tomur attack and transfer
10/28/2003US6639055 Method for making humanized antibodies
10/28/2003US6639050 Synthetic genes for plant gums and other hydroxyproline-rich glycoproteins
10/23/2003WO2003087840A2 Protein involved in cancer
10/23/2003WO2003087338A2 Her-2 receptor tyrosine kinase molecules and uses thereof
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087306A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086446A1 Monomeric and dimeric fluorescent protein variants and methods for making same
10/23/2003WO2003086444A1 Use of transthyretin peptide/protein fusions to increase the serum half-life of pharmacologically active peptides/proteins
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086308A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection
10/23/2003WO2003086175A2 Compositions and methods for the therapy and diagnosis of lung cancer
10/23/2003WO2003040164A3 Antigen arrays presenting il-5, il-3 or eotaxin for treatment of allergic eosinophilic diseases
10/23/2003WO2003031466A3 Angiotensin peptide-carrier conjugates and uses thereof
10/23/2003WO2003010201A3 Blood group antigen fusion polypeptides and methods of use thereof
10/23/2003WO2002099084A3 Composite binding polypeptides
10/23/2003WO2002097042A3 Chimeric proteins for cell targeting and apoptosis induction and methods of using the same
10/23/2003WO2002081519A3 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/23/2003WO2002077199A3 Methods and products related to fgf dimerization
10/23/2003WO2002044336B1 Method of making a protein polymer and uses of the polymer
10/23/2003WO2002036806A3 Expression vectors able to elicit improved immune response and methods of using same
10/23/2003WO2001068805A3 Human olfactory receptors and genes encoding same
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199043 Therapeutic proteins (including polypeptide, antibody, peptide or fragment or variants)fused to albumin or fragment or variant linked by a linker peptide; nonglycosylated
10/23/2003US20030199040 First fusion polypeptide is linked to a second fusion polypeptide via disulfide bond between the heavy chain and light chain polypeptide, where in the first polypeptide binds interleukin-18
10/23/2003US20030199020 Chimeric heteromultimer adhesins
10/23/2003US20030198956 Staged assembly of nanostructures
10/23/2003US20030198946 Hepatitis-C virus testing
10/23/2003US20030198681 Method of making a protein polymer and uses of the polymer
10/23/2003US20030198649 HBV core antigen particles with multiple immunogenic components attached via peptide ligands
10/23/2003CA2481827A1 Polyvalent cation-sensing receptor in atlantic salmon
1 ... 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 ... 295